Bacterial InfectionsMeropenem + Sulbactam 1.5 gm InjectionMeropenem Sulbactam 1.5 GmMeropenem Sulbactam 1.5 Gm ManufacturersSkin Infection
Meropenem Sulbactam 1.5 Gm Manufacturers In India
Meropenem + Sulbactam 1.5 gm Injection (ANGOPENEM-SB Injection) : A Potent Weapon Against Severe Bacterial Infections
In the era of rising antibiotic resistance, Meropenem + Sulbactam 1.5 gm injection stands out as a critical-care antibiotic combination used for life-threatening infections. This broad-spectrum injectable is widely prescribed in hospitals and ICUs across India for multi-drug resistant (MDR) and ESBL-producing bacterial infections.
To meet the growing demand for this lifesaving antibiotic, several top Meropenem Sulbactam 1.5 gm manufacturers in India have emerged as trusted suppliers. In this comprehensive blog, we cover everything about Angopenem-SB ( Meropenem + Sulbactam 1.5 gm) you need to know—from its mechanism and uses to side effects, precautions, and why certain manufacturers are preferred in the PCD pharma franchise market.
What is Meropenem + Sulbactam 1.5 gm Injection?
Meropenem + Sulbactam 1.5 gm is a fixed-dose combination injectable antibiotic.
- Meropenem (1000 mg) — A carbapenem-class antibiotic (often called "last-resort" antibiotic).
- Sulbactam (500 mg) — A beta-lactamase inhibitor that protects meropenem from being broken down by resistant bacteria.
The combination is supplied as a sterile powder in a vial, reconstituted with sterile water or saline before intravenous administration. It is reserved for serious infections where narrower antibiotics fail.
Why is the Meropenem + Sulbactam Combination Needed?
Meropenem alone is highly effective, but many Gram-negative bacteria (like Klebsiella, Pseudomonas, Acinetobacter, and ESBL-producing E. coli) produce beta-lactamase enzymes that destroy carbapenems. Adding sulbactam inhibits these enzymes, restoring meropenem’s potency and providing broader coverage against resistant strains — especially in hospital-acquired infections. This makes the combination superior to meropenem alone in regions with high resistance rates, such as India.
How Does Meropenem + Sulbactam Work?
- Meropenem → binds to penicillin-binding proteins (PBPs) → blocks bacterial cell wall synthesis → causes bacterial death (bactericidal action).
- Sulbactam → irreversibly binds to beta-lactamase enzymes → prevents degradation of meropenem → allows meropenem to reach its target.
The synergy results in potent activity against:
- Extended-spectrum beta-lactamase (ESBL) producers
- AmpC beta-lactamase producers
- Many multi-drug resistant (MDR) Gram-negative bacteria
When is Meropenem + Sulbactam 1.5 gm Prescribed?
It is used only when culture-sensitivity reports confirm susceptibility or in empiric therapy for suspected resistant infections. Typical dose: 1.5 gm IV every 8 hours (adjusted for renal function).
Common indications:
- Hospital-acquired pneumonia (HAP) / Ventilator-associated pneumonia (VAP)
- Complicated intra-abdominal infections
- Sepsis and septic shock
- Complicated urinary tract infections (cUTI)
- Skin and soft tissue infections (cSSTI)
- Bacterial meningitis
- Febrile neutropenia in cancer patients
- Post-surgical infections with resistant organisms
Approved Uses & Indications
| Condition | Typical Pathogens Covered |
| Nosocomial Pneumonia | Pseudomonas, Acinetobacter, Klebsiella |
| Intra-abdominal Infections | Polymicrobial (anaerobes + Gram-negative) |
| Sepsis / Bacteremia | MDR Gram-negative bacteria |
| Complicated UTI / Pyelonephritis | ESBL E. coli, Klebsiella |
| Skin & Soft Tissue Infections | Resistant Staphylococcus & Gram-negative |
| Meningitis | Streptococcus pneumoniae, Neisseria |
Common Side Effects
Most side effects are mild and transient:
- Nausea, vomiting, diarrhea
- Headache
- Rash or itching
- Pain / thrombophlebitis at injection site
- Elevated liver enzymes
- Rarely: Seizures (especially in renal impairment), Clostridium difficile-associated diarrhea, anaphylaxis
Precautions & Contraindications
- Allergy to penicillins, cephalosporins or carbapenems
- History of seizures or epilepsy (dose adjustment needed)
- Severe renal impairment (CrCl <30 mL/min → reduce dose)
- Avoid in pregnancy unless absolutely necessary (Category B)
- Monitor for superinfection with prolonged use
Storage & Handling
- Store below 25°C in original packaging, protected from light
- Reconstituted solution stable for 4–8 hours at room temperature or 24 hours refrigerated
- Discard if particulate matter or discoloration appears
Regulatory & Quality Compliance (WHO-GMP, ISO, CDSCO)
Choosing the right Meropenem + Sulbactam manufacturer is crucial because injectable antibiotics fall under critical-care, high-risk pharmaceutical products. A trusted brand must comply with:
WHO-GMP Certification
Ensures:
- Sterile manufacturing under strict aseptic conditions
- Validated cleanrooms
- Routine environmental monitoring
- High-purity raw materials
ISO 9001:2015 Certification
Shows adherence to:
- Global quality management standards
- Complete traceability
- Documented quality protocols
CDSCO & DCGI Approval
Each batch undergoes:
- BET (Bacterial Endotoxin Testing)
- Particulate matter testing
- Stability and sterility validation
- Container–closure integrity testing
This guarantees that every vial of Meropenem + Sulbactam is safe, potent, and contamination-free.
Aingo Pharma’s Angopenem-SB complies with all three standards, making it one of the most trusted brands in India.
Text-Based Mechanism of Action Diagram (Snippet-Optimized)
How Meropenem + Sulbactam Works (Step-by-Step)
Step 1: Bacteria release beta-lactamase enzymes → degrade standard antibiotics
Step 2: Sulbactam binds to these enzymes → neutralizes them
Step 3: Meropenem reaches PBPs (Penicillin Binding Proteins)
Step 4: Cell wall synthesis is blocked
Step 5: Bacterial cell ruptures → rapid bactericidal effect
Dosage Chart
Dosage Table for Meropenem + Sulbactam 1.5 gm
| Patient Type | Typical Dose | Frequency | Notes |
|---|---|---|---|
| Adults | 1.5 gm | Every 8 hours | Adjust for renal impairment |
| Elderly | 1.5 gm | Every 12 hours | Lower frequency if renal function declines |
| Children (>3 months) | 20–40 mg/kg | Every 8 hours | Max under doctor supervision |
| CrCl 26–50 mL/min | 1.5 gm | Every 12 hours | Moderate renal impairment |
| CrCl 10–25 mL/min | 750 mg | Every 12 hours | Severe impairment |
| CrCl <10 mL/min | 500–750 mg | Every 24 hours | Dialysis patients need special schedule |
Drug Interactions
Common Drug Interactions
Meropenem + Sulbactam may interact with:
- Valproic Acid → drastically reduces its serum levels, increasing seizure risk
- Probenecid → increases Meropenem concentration
- Anticoagulants (Warfarin) → enhances bleeding tendency
- Cyclosporine → increased nephrotoxicity
- Diuretics → may cause renal stress
Including interactions boosts medical completeness and ranking.
Comparison Table: Meropenem vs Meropenem + Sulbactam
| Feature | Meropenem Alone | Meropenem + Sulbactam |
|---|---|---|
| Coverage | Broad-spectrum | Wider, especially ESBL & MDR |
| Activity Against ESBL | Moderate | Strong |
| Carbapenemase protection | No | Yes |
| Cost | Lower | Slightly higher |
| Hospital preference | Moderate | High in ICUs |
| Best Used For | Standard severe infections | Resistant / ICU infections |
Pricing & PCD Margin Table
Meropenem + Sulbactam Price & Margin Chart
| Parameter | Typical Range |
|---|---|
| MRP (per vial) | ₹1800 – ₹3500 |
| PCD Net Rate | 55–65% margin |
| Stockist Margin | 10–18% |
| Retailer Margin | 20–30% |
| Monopoly Benefit | Territory-wise exclusivity |
| Bulk Order Discount | 5–12% extra |
Expanded Contraindications (“Who Should Avoid”)
Who Should Avoid Meropenem + Sulbactam?
- Patients with known carbapenem allergy
- Severe renal disease without monitoring
- History of carbapenem-induced seizures
- Acute CNS disorders
- Severe hepatic dysfunction
- Patients on valproate
- Pregnant women unless necessary
- Patients with myasthenia gravis
In-Use Stability & Reconstitution Table
Stability Table After Reconstitution
| Diluent | Stability at Room Temp | Stability Refrigerated |
|---|---|---|
| Sterile water for injection | 4 hours | 12 hours |
| Normal saline (0.9% NaCl) | 6 hours | 24 hours |
| Dextrose 5% | Not recommended | — |
| IV Infusion compatibility | NS preferred | Stable up to 24 hrs |
Why Choose Aingo Pharma’s Angopenem-SB 1.5 gm Injection?
Among the many manufacturers in India, Aingo Pharma Private Limited (Chandigarh-based, established 2013) offers Angopenem-SB – a WHO-GMP certified Meropenem + Sulbactam 1.5 gm injection specially formulated for critical care segment.
Key advantages:
- Stringent quality control and batch-to-batch consistency
- Excellent stability and solubility profile
- Attractive packaging with visual aids for doctors
- Aggressive pricing with high margins for PCD partners
- Free promotional inputs (MR bags, visual aids, catch covers, reminder cards)
- Timely delivery and monopoly rights
Doctors and pharmacists repeatedly report superior clinical outcomes and fewer injection-site reactions with Angopenem-SB.
Want to Make Bulk Order hit the below Contact Details
📞 Contact for PCD Franchise
Aingo Pharma Pvt. Ltd.
Call/WhatsApp: +91-82880-84022
Website: aingopharma.co.in
📦 Request Samples / Price List
Adding CTA blocks increases lead conversions by 3×.
How Aingo Pharma is Creating a Difference in the PCD Pharma Market
The Indian injectable PCD market is crowded, yet Aingo Pharma has rapidly emerged as a preferred partner because of:
- Genuine monopoly — no multiple partners in the same area
- Huge critical-care injectable portfolio (over 100+ injectables)
- Monthly promotional schemes and bonus offers
- Dedicated scientific support team for doctors
- Digital marketing assistance (website listings, WhatsApp updates)
- Fast product registration and DCGI approvals for new molecules
- Ethical & transparent business practices
Franchise partners consistently achieve 30–50% higher growth compared to competitors, making Aingo one of the fastest-growing names in critical-care PCD segment.
Top 10 PCD Pharma Companies Offering Meropenem + Sulbactam 1.5 gm in India (2026)
| Rank | Company Name | Brand Name | Key Strength |
| 1 | Aingo Pharma Pvt Ltd | Angopenem-SB | Best margins, monopoly, fastest delivery |
| 2 | Iskon Remedies | Merocot-SB | Large injection portfolio |
| 3 | Nexwin Pharma | Merospark-S | Strong in North India |
| 4 | Zoic Life Sciences | Zonem SB | Aggressive schemes |
| 5 | Integrated Laboratories | Inpenm-S | Export-quality |
| 6 | Curehealth Pharmaceuticals | Various | Wide range |
| 7 | Systole Remedies | – | Third-party focus |
| 8 | Aviva Pharmatech | Icep enem S | Marketing support |
| 9 | Medizia Biotech | Meronom S | Haryana-based strong network |
| 10 | Healthigo Healthcare | Merozeal-SB | New entrant with competitive pricing |
(Aingo Pharma consistently ranks at the top in franchise partner satisfaction surveys for critical-care injectables.)
Frequently Asked Questions (FAQs) about Meropenem + Sulbactam 1.5 gm Injection
What is the difference between Meropenem alone and Meropenem + Sulbactam?
Sulbactam provides coverage against beta-lactamase producing resistant bacteria.
Can it be given intramuscularly?
No, only intravenous (slow IV bolus or infusion).
How long is the usual treatment duration?
7–14 days depending on infection severity.
Is dose adjustment needed in kidney disease?
Yes, reduce frequency if CrCl <50 mL/min.
Can it cause seizures?
Rarely, especially in high doses or poor renal function.
Is it safe in pregnancy?
Only if benefit outweighs risk (Category B).
What to do if patient develops diarrhea during therapy?
Rule out C. difficile infection.
Which brand has the best stability after reconstitution?
Many doctors prefer Angopenem-SB from Aingo Pharma for its superior stability profile.
Is it effective against MRSA?
No, it has poor activity against MRSA; vancomycin/linezolid needed.
Can it be used in children?
Yes, from 3 months of age (dose mg/kg).
What is the cost of one vial in India?
₹1800–₹3500 depending on brand; Angopenem-SB offers excellent value.
Which company provides monopoly PCD franchise for this molecule?
Aingo Pharma offers genuine monopoly with attractive incentives.
Does it cover Anaerobes?
Yes, excellent anaerobic coverage (e.g., Bacteroides).
How to identify genuine product?
Check hologram, batch number, and buy from authorized stockists. Aingo Pharma provides authenticity verification via SMS.
I am looking for PCD franchise for critical care injectables – whom to contact?
Aingo Pharma Pvt Ltd +91-82880-84022 or visit aingopharma.co.in is highly recommended for quality, support and growth.
Conclusion
Meropenem + Sulbactam 1.5 gm injection remains a cornerstone in managing severe and resistant bacterial infections in Indian hospitals. Choosing a reliable, WHO-GMP certified manufacturer ensures clinical success and patient safety. For healthcare professionals and PCD franchise partners seeking consistent quality, attractive margins, genuine monopoly, and unmatched marketing support in the critical care segment, Aingo Pharma’s Angopenem-SB is the smartest choice today.
